thromboxanes has been researched along with Cerebrovascular Disorders in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (73.33) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, N; Chen, Q; Chen, W; Liu, H; Sun, C; Wang, X; Xu, Z; Zheng, Z; Zhou, Z | 1 |
| Jacobsen, DC | 1 |
| Hillbom, ME; Hjelm-Jäger, M; Kangasaho, M | 1 |
| Nilsson, IM; Saldeen, P; Saldeen, T | 1 |
| de Boer, AC; Genton, E; Turpie, AG | 1 |
| Castaldi, PA | 1 |
| Matsuzawa, T; Ohtsu, E | 1 |
| Abe, H; Fujisawa, A; Imaizumi, M; Kimura, K; Kusunoki, M; Matsumoto, M; Uyama, O; Yoneda, S | 1 |
| Imaizumi, M; Kayama, N; Matsumoto, M; Miyamoto, T; Nukada, T; Uyama, O; Yoneda, S | 1 |
| Mayhan, WG | 1 |
| Hohlfeld, T; Przytulski, B; Schanz, A; Schrör, K; Weber, AA | 1 |
| Fuccella, LM | 1 |
| Böshagen, H; Fiedler, VB; Perzborn, E; Rosentreter, U; Sander, E; Seuter, F; Stasch, JP; Weber, H | 1 |
| Pickard, JD; Walker, V | 1 |
| Lecompte, T; Samama, M | 1 |
4 review(s) available for thromboxanes and Cerebrovascular Disorders
| Article | Year |
|---|---|
Prostaglandins and cardiovascular disease--a review.
Topics: Arachidonic Acids; Arteriosclerosis; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Epoprostenol; Extracorporeal Circulation; Fetus; Homeostasis; Humans; Prostaglandin Antagonists; Prostaglandins; Pulmonary Embolism; Shock; Thromboxanes | 1983 |
Platelet consumption in cardiovascular disease.
Topics: Angina Pectoris; Animals; Arterial Occlusive Diseases; Arteriosclerosis; Blood Platelets; Cardiovascular Diseases; Cell Survival; Cerebrovascular Disorders; Coronary Disease; Death, Sudden; Heart Valve Diseases; Humans; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests; Rabbits; Radionuclide Imaging; Thromboembolism; Thrombosis; Thromboxanes | 1982 |
Clinical pharmacology of inhibitors of platelet aggregation.
Topics: Bleeding Time; Blood Coagulation Disorders; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Coronary Disease; Dose-Response Relationship, Drug; Epoprostenol; Humans; In Vitro Techniques; Ischemia; Platelet Aggregation; Thrombophlebitis; Thromboxanes | 1979 |
Prostaglandins, thromboxane, leukotrienes and the cerebral circulation in health and disease.
Topics: Animals; Arachidonic Acids; Brain; Brain Edema; Brain Ischemia; Cerebrovascular Circulation; Cerebrovascular Disorders; Eicosanoic Acids; Epoprostenol; Fatty Acids, Unsaturated; Humans; Indomethacin; Intracranial Embolism and Thrombosis; Ischemic Attack, Transient; Leukotriene B4; Lipid Peroxides; Muscle, Smooth, Vascular; Platelet Aggregation; Prostaglandins; Thromboxanes | 1985 |
2 trial(s) available for thromboxanes and Cerebrovascular Disorders
| Article | Year |
|---|---|
Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Collagen; Coronary Disease; Dipyridamole; Evaluation Studies as Topic; Humans; Myocardial Infarction; Platelet Aggregation; Prostaglandins; Recurrence; Sulfinpyrazone; Thromboxanes | 1981 |
A critical appraisal of the clinical efficiency of anti-platelet drugs.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Double-Blind Method; Hemorrhage; Humans; Myocardial Revascularization; Prospective Studies; Sulfinpyrazone; Thromboxanes | 1986 |
9 other study(ies) available for thromboxanes and Cerebrovascular Disorders
| Article | Year |
|---|---|
Perioperative urinary thromboxane metabolites and outcome of coronary artery bypass grafting: a nested case-control study.
Topics: Cardiovascular Diseases; Case-Control Studies; Cerebrovascular Disorders; Coronary Artery Bypass; Female; Humans; Male; Middle Aged; Perioperative Period; Postoperative Complications; Risk Factors; Thromboxanes | 2018 |
Platelet aggregation and thromboxane B2 formation after ethanol abuse: is there a relationship to stroke?
Topics: Adult; Alcoholism; Cerebrovascular Disorders; Humans; Male; Platelet Aggregation; Substance Withdrawal Syndrome; Thromboxane A2; Thromboxanes | 1984 |
Increased synthesis of thromboxane B2 and 6-keto-PGF1 alpha in hand veins from patients with deep venous thrombosis.
Topics: Adolescent; Adult; Aged; Cerebrovascular Disorders; Female; Fibrinolysis; Hand; Humans; Male; Middle Aged; Prostaglandins F; Thrombophlebitis; Thromboxane B2; Thromboxanes; Veins | 1983 |
Metabolic alterations in the endogenous formation of 6 keto-prostaglandin F1 alpha, thromboxane B2 and prostaglandin E2 in the brain-stem of stroke-resistant spontaneously hypertensive rats.
Topics: Animals; Brain Stem; Cerebrovascular Disorders; Hypertension; Male; Prostaglandins E; Prostaglandins F; Rats; Thromboxane B2; Thromboxanes | 1980 |
Plasma concentrations of thromboxane B2 in patients with hypertension or cerebrovascular disease.
Topics: Adolescent; Adult; Aged; Arteries; Aspirin; Cerebrovascular Disorders; Female; Humans; Hypertension; Jugular Veins; Male; Middle Aged; Thromboxane B2; Thromboxanes; Veins | 1981 |
Thromboxane generation in patients with essential hypertension or cerebrovascular disease and effect of oral aspirin.
Topics: Adolescent; Adult; Aged; Arachidonic Acids; Aspirin; Blood Platelets; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Middle Aged; Prostaglandins H; Thromboxane B2; Thromboxanes | 1980 |
Constrictor responses of the rat basilar artery during diabetes mellitus.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Arginine Vasopressin; Basilar Artery; Blood Pressure; Cerebrovascular Disorders; Diabetes Mellitus, Experimental; Endothelin-1; Enzyme Inhibitors; Male; Muscle, Smooth, Vascular; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Thromboxanes; Vasoconstriction; Vasoconstrictor Agents | 1998 |
Towards a definition of aspirin resistance: a typological approach.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Drug Resistance; Humans; Platelet Aggregation Inhibitors; Reference Values; Thromboxanes | 2002 |
Characterization of Bay U 3405, a novel thromboxane A2/endoperoxide receptor antagonist.
Topics: Adenosine Diphosphate; Animals; Aorta; Arachidonic Acid; Arachidonic Acids; Binding, Competitive; Carbazoles; Cerebrovascular Disorders; Collagen; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Rats; Rats, Inbred SHR; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboembolism; Thromboxanes; Vasoconstriction | 1990 |